Hyperhaploid clones (24-34 chromosomes) were identified in 33 patients with multiple myeloma (MM), demonstrating a novel numerical cytogenetic subgroup. Strikingly, all hyperhaploid karyotypes were found to harbor monosomy 17p, the single most important risk stratification lesion in MM. A catastrophic loss of nearly a haploid set of chromosomes results in disomies of chromosomes 3, 5, 7, 9, 11, 15, 18, 19 and 21, the same basic set of odd-numbered chromosomes found in trisomy in hyperdiploid myeloma. All other autosomes are found in monosomy, resulting in additional clinically relevant monosomies of 1p, 6q, 13q and 16q. Hypotriploid subclones (58-68 chromosomes) were also identified in 11 of the 33 patients and represent a duplication of the hyperhaploid clone. Analysis of clones utilizing interphase fluorescence in situ hybridization (iFISH), metaphase FISH and spectral karyotyping identified either monosomy 17 or del17p in all patients. Amplification of 1q21 was identified in eight patients, demonstrating an additional high-risk marker. Importantly, our findings indicate that current iFISH strategies may be uninformative or ambiguous in the detection of these clones, suggesting this patient subgroup maybe underreported. Overall survival for patients with hyperhaploid clones was poor, with a 5-year survival rate of 23.1%. These findings identify a distinct numerical subgroup with cytogenetically defined high-risk disease.
INTRODUCTION
Multiple myeloma (MM) is a plasma cell disorder characterized by complex numerical and structural chromosome aberrations. 1 There is a consensus on two main numerical subgroups associated with different oncogenetic pathways and prognostic significance. 2 The largest numerical subgroup is composed of hyperdiploid (47-57 chromosomes) clones characterized by a consistent set of odd-numbered chromosomes including trisomies for chromosomes 3, 5, 7, 9, 11, 15, 19 and 21 . This group is found in 50 to 60% of patients, contains fewer structural immunoglobulin heavy-chain (IGH) translocations and is associated with a better prognosis. The second subgroup is made up of nonhyperdiploid (hypodiploid) karyotypes with 35-45 chromosomes, and is characterized by the loss of chromosomes 13, 14, 16 and 22. The hypodiploid group contains more frequent structural aberrations involving adverse IGH translocations, and is associated with a worse prognosis. 3 Hyperhaploidy is a rare numerical aberration group defined by a range of 24-34 chromosomes 4 that has been identified in many disease entities. 5 We and others have previously reported a small number of hyperhaploid karyotypes in MM; [5] [6] [7] [8] [9] [10] however, hyperhaploidy is most consistently identified and recognized as a category for numerical aberrations in childhood acute lymphoblastic leukemia (ALL). 11 In childhood ALL the hyperhaploid clones occur in two subgroups, a near-haploid group (25-29 chromosomes) and low hypodiploidy subgroup (30-39 chromosomes). 11 A distinctive set of five chromosomes occurs in hyperhaploid ALL with disomies of the X, Y, 14, 18 and 21. 11 In MM the hyperhaploid clone is characterized by a set of mostly odd-numbered disomies including 3, 5, 7, 9, 11, 15, 18, 19 and 21 . Of note, in MM this is the same set of odd-numbered chromosomes found as trisomies in hyperdiploid myeloma, with the exception that chromosome 18 is retained in disomy in most of these cases. Importantly, multiple chromosome regions associated with deletions and poor prognosis are inherently monosomic in these clones, including chromosome regions 17p, 1p, 13q and 16q. 1 In MM, cytogenetic risk stratification models rely on a number of independent molecular markers to assess disease aggressiveness. [12] [13] [14] [15] [16] [17] Among current models there is a consensus that deletion of 17p is the single most important interphase fluorescence in situ hybridization (iFISH) probe for prognostication. The International Myeloma Working Group (IMWG) recommends the use of three independent iFISH probes to identify cytogenetically defined high-risk disease, including probes for t(4;14), del17p13 and gain of 1q21. 17 The del17p13 and gain of 1q21 are secondary copy number aberrations (CNAs) associated with disease progression and relapse. The universal finding of monosomy 17 in hyperhaploid clones indicates that these patients detected by iFISH would be classified as high risk according to the IMWG and other stratification models. The significance of monosomy 17p in relation to risk stratification, the emergence of hypotriploid subclones with CNAs 'masked' to iFISH, and accumulation of secondary amplification of 1q21 have not been reported.
informed consent approving the use of their samples for research purposes. Patients with hyperhaploid clones were identified by routine G-banded studies of clinical specimens. Locus-specific BAC probes for iFISH included 1q21 (CKS1B), 1p13 (AHCYL1), 13q14 (D13S31), 13q34 (D13s285), 17p (TP53), and 17q24 (ERB2), and hybridizations were performed as previously described. 18 A 20% cutoff point was used for detection of numerical aberrations. Metaphase FISH (mFISH) and Spectral Karyotyping (SKY) were utilized in cases with adequate cell pellet available following G-banding procedures. mFISH probes also included commercial probes for IGH (break-apart probe), and probes to the pericentromeric regions of 1q12 (sat III DNA, red), 9q11 (alpha sat, aqua) and 16q11 (sat II, aqua) (Vysis, Downers Grove, IL, USA). Probes were used according to the manufacturer's instructions. The SKY probe mixture and hybridization reagents were prepared by Applied Spectral Imaging (Carlsbad, CA, USA). Image acquisition for FISH and SKY was performed as previously described 19 using a SD200 Spectracube (Applied Spectral Imaging, Inc., Carlsbad, CA, USA) mounted on a Zeiss Axioplan II microscope (Gottingen, Germany). DAPI (4',6-diamidino-2-phenylindole) images were captured, then inverted and enhanced by SKYView software to produce G-band patterns on the chromosomes. Original magnification of all G-band and iFISH images was × 1000. Original magnification for SKY images was × 630.
Statistical analysis
Overall survival curves were constructed according to the Kaplan-Meier method. 20 A total of 33 hyperhaploid patients with overall survival (OS) data landmarked by cytogenetic analysis were compared with total therapy 3 (TT3) 21 Abbreviations: DS, Durie Salmon; F, female; FISH, fluorescence in situ hybridization; ISS, International Staging System; L-chain, light chain; M, male; Pt, patient.
hyperhaploid cases. In addition, missing clinical values in a subset of hyperhaploid cases were imputed using multivariate imputation by chained equations, 24 and subsequent Cox regression models were pooled to increase overall power with all hyperhaploid samples included.
RESULTS

Patient characteristics including age, sex, isotype, L-chain, Durie
Salmon staging, ISS and composite G-band karyotypes of all 33 patients are presented in Table 1 . The iFISH results for 13 patients are presented in Supplementary Table 1 and mFISH results for 11  patients in Supplementary Table 2 . Chromosome numbers (derived from karyotype data) ranged from 30 to 34, with a modal number of 32 in the hyperhaploid clones, whereas the hypotriploid subclones showed a modal number of 66 chromosomes ( Table 1 ). The hyperhaploid clones showed the same set of odd-numbered chromosomes found as disomies including 3, 5, 7, 9, 11, 15, 19 and 21 that are found as trisomies in hyperdiploid MM (not shown). The notable exception to this in the hyperhaploid clones is that all or part of chromosome 18 was retained in disomy in most patients (26/33) ( Table 1) . By G-banding only hyperhaploid clones were identified in 20 patients, whereas both hyperhaploid and hypotriploid subclones were found in 11 patients, and only hypotriploid clones in 2 patients (Table 1) . Spectral karyotyping of patient no. 33 demonstrated how the exact doubling of chromosomes in a hyperhaploid clone (Figure 1a ) can result in a hypotriploid clone (Figure 1b) . Rehybridization of the same cells with IMWG 17 probes for IGH, 17p and 1q21 shows single (normal) copies of all chromosomes probed (Figure 1c) , whereas the hypotriploid cell shows two (normal) copies of all probes (Figure 1d ). Analysis of patients for IGH translocations identified one patient each with a t(11;14)(q13;q32) (no. 11) (Table 1) , a t(4;14) (no. 9) and a t(6;14) (no. 32) (Supplementary Table 2 ).
The iFISH identified 11 of 13 patients as monosomic for chromosomes 1, 13 and 17 (Supplementary Table 1) . Unexpectedly, discordant findings were found between the iFISH and G-band studies in three patients. Two patients (nos. 26 and 33) showed iFISH results with two copies for all iFISH probes, instead of the expected one (Supplementary Table 1 ). This discrepancy was traced to a 20% cutoff calculation for numerical aberrations used in the iFISH analysis. 25, 26 In review, patient no. 26 showed monosomy in 3-8% of cells and patient no. 33 showed monosomy in 2-11% of cells, both below the cutoff value. These findings indicate the need for reevaluation of the widely used 20% cutoff for the detection of numerical aberrations by iFISH. 25, 26 Equally important is that in these patients hypotriploid clones are 'masked' to the current IMWG probe set if they are normal for IGH and show two copies for 17p and 1q21 (Figure 1b) . The third patient (no. 32) with a discrepancy between iFISH and G-band results showed monosomy 1 and monosomy for 17p, but also showed two copies of 17q (Figure 2a and Supplementary Table 1) . A subsequent G-band specimen resolved the discrepancy by analysis with mFISH and SKY that showed a derivative whole-arm translocation of 19p to 17q (Figure 2b) , resulting in the deletion of 17p (Figure 2c ). This result demonstrates an unexpected iFISH pattern for monosomy 17p in hyperhaploid clones occurs by whole-arm translocations (Figure 2c) , and secondary amplification of 1q21 by a jumping translocation of 1q12 (JT1q12) (Figure 2c) .
Metaphase FISH identified a single copy of 17p in the hyperhaploid clones of all 11 patients tested, and two copies of 17p, as expected, in the hypotriploid clones (Supplementary Table 2 ). Importantly, no evidence of hyperdiploid or nonhyperdiploid clones was found in any patient by G-banding, iFISH or mFISH, indicating that hyperhaploid clones most likely arise independently of the other ploidy groups in MM.
Gain of 1q21 was identified in seven patients (nos. 6, 10, 17, 18, 27, 30 and 32) by G-banding (Table 1) . Five patients (nos. 17, 18, 27, 30 and 32) had adequate sample for further mFISH and/or SKY analysis. mFISH probes for 1q12 and 1q21 identified amplification of 1q21 as direct duplications of 1q21-31 in two patients (nos.17 and 27), and three with JT1q12 (nos. 18, 30 and 32). Strikingly, one case (no. 30) showed high levels of 1q21 amplification originating on two different chromosomes: at both 1q12 as expected, and also on a receptor chromosome 3. In this patient, a CN of 2 was found in the hyperhaploid clone (amplified in the context of hyperhaploidy) resulting from a JT1q12 to the telomere of the short arm of receptor chromosome 3 (Figure 3a) . Intraclonal heterogeneity for 1q21 CNs in this patient ranged from 2 to 4 in the hyperhaploid clone as a result of triradials of chromosome 1q12 (Figure 3b), iso1q21 (Figure 3c ) and triradials of 3p (Figures 3d and e) . The doubling of all the chromosomes to a hypotriploid subclone (Figure 3f ) resulted in a CN of 8 for 1q21 (Figure 3g ). The finding of triradials and multiradials originating on two different chromosomes (1q12 and 3pter) is rare and demonstrates that 1q12 pericentromeric heterochromatin can increase CN of 1q21 regardless of its genomic position.
OS and multivariate analysis The OS for 33 hyperhaploid patients indicates poor prognosis, with a 5-year survival rate of 23.1% (Figure 4a ). When compared with cases from TT3, hyperhaploids have a significantly worse prognosis than hypodiploid cases with a log rank P-value of 0.015 (Figure 4a ). Outcome of hyperhaploids is equivalent with that of the highest risk forms of multiple myeloma: cases with ISS stage III and GEP70 high risk (HR) (log rank P-value 0.413, Figure 4b) .
A comparative univariate analysis between hyperhaploid cases and TT3 cases, split by GEP70 risk, revealed that hyperhaploid cases are similar to TT3 low-risk cases in all clinical features but lactate dehydrogenase (Table 2a ). Hyperhaploid cases were statistically different from TT3 GEP70 HR cases according to the proportion of ISS Stage III cases with each group (15.4% in HH vs 48.7% in GEP70 HR). A multivariate model determined through backward selection identified age, ISS Stage III, C-reactive protein, presence of an abnormal karyotype and hyperhaploidy as significant independent prognostic factors (Table 2b) . Hypodiploid status did not retain significance following stepwise selection, indicating that the presence of hyperhaploidy adds greater prognostic value than hypodiploidy alone. Overall, these analyses indicate that hyperhaploid cases may have similar clinical features as low-risk disease with an outcome that is at par with the highest risk form of myeloma.
DISCUSSION
Based on cytogenetic and molecular studies, MM is considered to be composed of many disease entities with two main numerical subtypes. The largest is the hyperdiploid subtype with higher chromosome numbers and recurring trisomies of chromosome 3, 5, 7, 9, 11, 15, 19 and 21. The second major subtype is the hypodiploid (nonhyperdiploid) group without trisomies and with one of several IgH rearrangements. The hypodiploid group is characterized by the loss of chromosomes 13, 14, 16 and 22, and adverse IGH translocations including the t(4;14), t(14;16) and t (14;20) .
Here we report a subtype of MM composed of hyperhaploid clones and hypotriploid subclones. These distinctive karyotypes resemble hyperdiploid clones in two ways. First, the numerical aberrations involve essentially the same set of autosomes in disomy instead of trisomy, with the exception of the chromosome 18. Second, based on our limited numbers, these clones have fewer IGH translocations (Table 1 and Supplementary Table 2 ). The origins of numerical aberrations in MM are currently unknown. It is intriguing that the same set of chromosomes found in disomy in these hyperhaploid clones are found in trisomies in hyperdiploid clones. This suggests the possibility that the origin of these different clones somehow involves the same set of chromosomes that are aligned on the mitotic plaque in a similar manner, but undergo different segregation patterns because of variations in the spindle apparatus and/or centrosome defects. [27] [28] [29] It also seems plausible that the same types of spindle or centrosome defects that result in the catastrophic loss of a haploid set of chromosomes in hyperdiploid ALL 30, 31 also result in the catastrophic loss of chromosomes in hyperhaploid MM. Although it is tempting to speculate that the hyperhaploid clones result from the loss of a complete set of normal chromosomes from a hyperdiploid cell, we found no evidence of hyperdiploid clones in any of the patients analyzed. Accordingly, these clones appear to arise independently of hyperdiploid clones by a catastrophic loss of chromosomes from a diploid cell, as has been found in other hyperhaploid malignancies. 5, 11 In patients with MM, the major clones are believed to be most responsible for prognosis, whereas minor clones are known to provide a reservoir for relapse. 31 Specific types of cytogenetic lesions such as 17p deletions when found in a higher proportion of cells are also known to be associated with shorter survival. Hyperhaploid cases have an outcome that is significantly worse than all other cytogenetic abnormalities, including hypodiploidy (hyperhaploidy vs hypodiploidy: log rank P-value of 0.015). In addition, the outcome of hyperhaploid cases is at par with the performance of patients exhibiting the highest risk features: those with ISS Stage III and GEP70 HR (hyperhaploid vs ISS III and GEP70 HR: log rank P-value of 0.413).
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Consequently, the ability to detect minor clones in patients harboring hyperhaploid and/or hypotriploid clones with monosomy 17p is clinically very important. 35 Our findings here, and those of others, suggest that an unknown number of patients with hypotriploid or near-triploid clones likely passed through a hyperhaploid stage without detection, and that the double chromosome number in a near-triploid clone can become the dominating clone and mask the presence of a hyperhaploid origin. 5, 11, 36 In this study both routine cytogenetics and iFISH strategies were uninformative in identifying certain clones. Metaphase cytogenetics is known to be uninformative because of the low proliferation of the plasma cells, whereas iFISH can be uninformative because of improper probe selection or inappropriate cutoff values. For example, in patients 26 and 33, iFISH results were uninformative (Supplementary Table 1) because of cutoff values set too high to detect the minor clones involving monosomies. The commonly used cutoff value for the interpretation of numerical abnormalities in MM is 20%, 25, 26 suggesting this value needs to be reevaluated for the detection of this novel subgroup of patients. Equally important is that in even with lower cutoffs, the hypotriploid subclones in these patients are cryptic or 'masked' to the presence of monosomy 17p because of the reduplication of all the chromosomes (Figure 2b ). These 'masked' clones occur in an as yet unknown number of patients. The probes sets for the detection of the common trisomies 3, 5, 7, 9, 11 and 15 in hyperdiploid myeloma can easily be misinterpreted as normal as hyperhaploid clones have the normal copy number for these chromosomes. Hypotriploid clones will be identified abnormal with two extra copies of 3, 5, 7, 9, 11 and 15; however, by iFISH this set of extra chromosomes will most likely be incorrectly interpreted as a tetraploid clone rather than a hypotriploid subclone (Figure 1c) .
The accumulation of secondary CNAs is a known mechanism for clonal evolution and intraclonal heterogeneity during the progression of MM. Secondary CNAs involving deletions of 1p and 13q are well documented in MM and it is believed that monosomies of these chromosomes are also clinically important. [37] [38] [39] Chromosome 1p has been shown to harbor a number of underexpressed genes and deletions of specific genes including CDKN2C, FAF1 and FAM46C, among others. 1 In fact, in addition to t(4;14) and del17p, the deletion of 1p32 has recently been shown to be a main factor negatively affecting survival. 38 Copy number gains of 1q21 are common in MM and in these 33 patients involved direct duplications of 1q21-23, whole-arm translocations of 1q12 and jumping translocations of 1q12 (JT1q12). 40, 41 As in hyperdiploid and nonhyperdiploid MM, instability of 1q12 pericentromeric heterochromatin was also a factor in the amplification of 1q21. The CN gains of 1q21 were identified originating from the formation of triradials of 1q12, but also on chromosome 3p (Figure 3) , and are thought to be associated with the hypomethylation of the 1q12 pericentromeric region. 42 The clinically important cytogenetic lesions in these karyotypes include several monosomies inherently present in these clones, including 17p,1p,13q and 16q. 1 Significantly, the reduplication of chromosomes in the hyperhaploid clones to a hypotriploid subclone results in these monosomic clones being duplicated and therefore becoming masked to the commonly used iFISH probes for the identification of CNAs. Our findings suggest that the current iFISH cutoff values and probe selections for the identification of these clones need to be reevaluated. Surprisingly, hyperhaploid clones result in the retention of disomies 3, 5, 7, 9, 11, 15, 18, 19 and 21 that, to our knowledge, represents the minimal disomic and monosomic chromosome constitution for a viable plasma cell clone. The total lack of trisomies and large number of monosomies in this subset of patients provides a unique patient group for multiple types of array and single-cell genomic analysis. 43 Recently, risk stratification in ALL has combined the use of genomic and cytogenetic data and has identified the near-haploidy and low hypodiploidy groups as poor risk. 44 In this group of patients, the OS was similarly poor, with a 5-year survival rate of 23.1% (Figure 4a ). In general, hyperhaploids have an outcome that is similar to cases with extremely adverse risk profiles-cases with ISS stage III and GEP70 HR. 23 The correct identification and interpretation of these distinctive clones is critical as risk stratification and treatment decisions are based in part on the iFISH detection of 17p and 1q21.
